Alexander Nowak
Stock Analyst at Craig-Hallum
(2.23)
# 1,472
Out of 4,412 analysts
33
Total ratings
40.74%
Success rate
-0.32%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $2.57 | +211.28% | 3 | Apr 24, 2024 | |
| NTRA Natera | Assumes: Buy | $117 | $91.66 | +27.65% | 2 | Apr 8, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $0.93 | +7.52% | 3 | Apr 1, 2024 | |
| CELC Celcuity | Maintains: Buy | $20 → $25 | $15.92 | +57.04% | 1 | Mar 28, 2024 | |
| BVS Bioventus | Maintains: Buy | $6 → $9 | $3.98 | +126.13% | 4 | Mar 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Hold | n/a | $39.64 | - | 4 | Feb 14, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $7.28 | +147.25% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $35.24 | +41.88% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $1.48 | +440.54% | 1 | May 12, 2023 | |
| CDNA CareDx | Downgrades: Hold | $26 → $9 | $7.56 | +19.05% | 2 | Mar 3, 2023 | |
| EXAS Exact Sciences | Downgrades: Hold | n/a | $58.85 | - | 1 | Oct 19, 2022 | |
| CVRX CVRx, Inc. | Initiates: Buy | $15 | $14.69 | +2.11% | 1 | Jul 18, 2022 | |
| NMTC NeuroOne Medical Technologies | Downgrades: Hold | n/a | $1.13 | - | 2 | Mar 28, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $11 | $2.30 | +378.26% | 1 | Jan 5, 2022 | |
| TECH Bio-Techne | Maintains: Buy | n/a | $64.06 | - | 1 | Feb 3, 2021 | |
| SENS Senseonics Holdings | Downgrades: Sell | n/a | $0.42 | - | 2 | Jan 20, 2021 | |
| VVOS Vivos Therapeutics | Initiates: Buy | $300 | $2.59 | +11,483.01% | 1 | Jan 11, 2021 | |
| INFU InfuSystem Holdings | Initiates: Buy | n/a | $8.12 | - | 1 | Aug 31, 2020 |
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $2.57
Upside: +211.28%
Natera
Apr 8, 2024
Assumes: Buy
Price Target: $117
Current: $91.66
Upside: +27.65%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $0.93
Upside: +7.52%
Celcuity
Mar 28, 2024
Maintains: Buy
Price Target: $20 → $25
Current: $15.92
Upside: +57.04%
Bioventus
Mar 13, 2024
Maintains: Buy
Price Target: $6 → $9
Current: $3.98
Upside: +126.13%
QuidelOrtho
Feb 14, 2024
Downgrades: Hold
Price Target: n/a
Current: $39.64
Upside: -
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $7.28
Upside: +147.25%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $35.24
Upside: +41.88%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $1.48
Upside: +440.54%
CareDx
Mar 3, 2023
Downgrades: Hold
Price Target: $26 → $9
Current: $7.56
Upside: +19.05%
Exact Sciences
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $58.85
Upside: -
CVRx, Inc.
Jul 18, 2022
Initiates: Buy
Price Target: $15
Current: $14.69
Upside: +2.11%
NeuroOne Medical Technologies
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.13
Upside: -
Stereotaxis
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.30
Upside: +378.26%
Bio-Techne
Feb 3, 2021
Maintains: Buy
Price Target: n/a
Current: $64.06
Upside: -
Senseonics Holdings
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.42
Upside: -
Vivos Therapeutics
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.59
Upside: +11,483.01%
InfuSystem Holdings
Aug 31, 2020
Initiates: Buy
Price Target: n/a
Current: $8.12
Upside: -